Literature DB >> 15812266

Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment.

Yong Min Ahn1, Jae Seung Chang, Yeni Kim, Kyu Young Lee, Jong Hoon Kim, Seong Chan Kim, So Jin Maeng, Yong Sik Kim.   

Abstract

The present study aimed to elucidate the effectiveness of clozapine treatment in reducing the disabling period of chronically ill schizophrenic patients by investigating their rehospitalization status. Of 232 schizophrenic patients with a history of clozapine use who were recruited from the clinic at Seoul National University Hospital, 117 were selected who had been followed up for more than 1 year with respect to rehospitalization. To obtain information about the period before the clozapine change, a chart review of these 117 patients was conducted. The number and length of hospitalizations of the patients significantly decreased after clozapine treatment compared to the same period before clozapine treatment. The hospital days per year of the patients were also decreased significantly after clozapine introduction. By analysing 38 patients who were followed up for more than 5 years, it was suggested that the decrease in the number and length of hospitalizations was substantially sustained for up to 5 years after clozapine treatment. This study showed that the number and length of hospitalizations are significantly decreased by long-term clozapine treatment and that this effect can positively affect the social outcome of schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812266     DOI: 10.1097/00004850-200505000-00006

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  2 in total

1.  Efficacy of clozapine for long-stay patients with treatment-resistant schizophrenia: 4-year observational study.

Authors:  Kentaro Mizuno; Emiko Mizuno; Akira Suekane; Toshiaki Shiratsuchi
Journal:  Neuropsychopharmacol Rep       Date:  2022-03-02

2.  Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine.

Authors:  Jad Kesserwani; Giouliana Kadra; Johnny Downs; Hitesh Shetty; James H MacCabe; David Taylor; Robert Stewart; Chin-Kuo Chang; Richard D Hayes
Journal:  J Psychopharmacol       Date:  2019-01-08       Impact factor: 4.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.